JPRN-UMIN000035375招募中未知
Early conversion to cabazitaxel for castration-resistant prostate cancer - ECOCAB
Sapporo Medical University School of Medicine0 个研究点目标入组 100 人开始时间: 2018年12月26日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. No previous cabazitaxel treatment 2. Active concomitant malignancy in 3 years except for prostate cancer 3. Difficult to control severe complications except for malignancy 4. Seizure to be treated with anticonvulsant 5. Severe liver dysfunction 6. Allergy for cabazitaxel, docetaxel and predonisolone 7. Neither ability nor will to cooperate the study 8. Unfit for enrollment by physician in charge
研究者
相似试验
进行中（未招募）
1 期
Study of the effect of chemotherapy with cabazitaxel on prostate cancerEUCTR2014-004485-21-GRHellenic Cooperative Oncology Group60
进行中（未招募）
不适用
2nd line treatment with cabazitaxel in patients with NSCLCPatients with stage IIIB with pleural effusion or stage IV NSCLC with documented disease progression during or after completion of docetaxel-based treatment are eligible for the study.EUCTR2012-000275-16-GRHellenic Oncology Research Group (H.O.R.G.)
进行中（未招募）
1 期
Cabazitaxel and Abiraterone Acetate in Patients with Metastatic Castrate-Resistant Prostate CancerMedDRA version: 14.1 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)prostate cancerEUCTR2011-001506-96-GBsanofi-aventis recherche et développement37
招募中
2 期
Early induction of docetaxel for castration resistance prostate cancerprostate cancerJPRN-UMIN000004072M-CURE65
已完成
2 期
Study of the Effect of Chemotherapy With Cabazitaxel on Prostate CancerBone Metastatic Prostate CancerNCT02512458Hellenic Cooperative Oncology Group60